Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats - PubMed (original) (raw)
. 2004 Oct;287(4):L665-72.
doi: 10.1152/ajplung.00050.2003. Epub 2003 Sep 5.
Affiliations
- PMID: 12959926
- DOI: 10.1152/ajplung.00050.2003
Free article
Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats
Tetsutaro Nagaoka et al. Am J Physiol Lung Cell Mol Physiol. 2004 Oct.
Free article
Abstract
Recent evidence suggests that Rho/Rho kinase signaling plays an important role in the sustained vasoconstriction induced by many agonists and is involved in the pathogenesis of systemic vascular diseases. However, little is known about its role in increased vascular tone in hypoxic pulmonary hypertension (PH). The purpose of this study was to examine whether Rho/Rho kinase-mediated Ca2+ sensitization contributed to sustained vasoconstriction and increased vasoreactivity in hypoxic PH in rats. Acute intravenous administration of Y-27632, a Rho kinase inhibitor, nearly normalized the high pulmonary arterial blood pressure and total pulmonary resistance in chronically hypoxic rats. In contrast to nifedipine, Y-27632 also markedly decreased elevated basal vascular tone in hypertensive blood-perfused lungs and isolated pulmonary arteries. Y-27632 and another Rho kinase inhibitor, HA-1077, completely reversed nitro-L-arginine-induced vasoconstriction in physiological salt solution-perfused hypertensive lungs, whereas inhibitors of myosin light chain kinase (ML-9), protein kinase C (GF-109203X), phosphatidylinositol 3-kinase (LY-294002), and tyrosine kinase (tyrphostin A23) caused only partial or no reversal of the vasoconstriction. Vasoconstrictor responses to KCl were augmented in hypertensive physiological salt solution-perfused lungs and pulmonary arteries, and the augmentation was eliminated by Y-27632. These results suggest that Rho/Rho kinase-mediated Ca2+ sensitization plays a central role in mediating sustained vasoconstriction and increased vasoreactivity in hypoxic PH.
Similar articles
- Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.
Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Casey DB, et al. Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H184-92. doi: 10.1152/ajpheart.00181.2009. Epub 2010 Apr 30. Am J Physiol Heart Circ Physiol. 2010. PMID: 20435851 Free PMC article. - Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats.
Weigand L, Sylvester JT, Shimoda LA. Weigand L, et al. Am J Physiol Lung Cell Mol Physiol. 2006 Feb;290(2):L284-90. doi: 10.1152/ajplung.00449.2004. Epub 2005 Sep 9. Am J Physiol Lung Cell Mol Physiol. 2006. PMID: 16155085 - Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.
Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. Fagan KA, et al. Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L656-64. doi: 10.1152/ajplung.00090.2003. Epub 2004 Feb 20. Am J Physiol Lung Cell Mol Physiol. 2004. PMID: 14977625 - Rho-kinase inhibitors show promise in pulmonary hypertension.
Doggrell SA. Doggrell SA. Expert Opin Investig Drugs. 2005 Sep;14(9):1157-9. doi: 10.1517/13543784.14.9.1157. Expert Opin Investig Drugs. 2005. PMID: 16144499 Review. - Rho kinase-mediated vasoconstriction in pulmonary hypertension.
McMurtry IF, Abe K, Ota H, Fagan KA, Oka M. McMurtry IF, et al. Adv Exp Med Biol. 2010;661:299-308. doi: 10.1007/978-1-60761-500-2_19. Adv Exp Med Biol. 2010. PMID: 20204738 Review.
Cited by
- Smooth muscle Acid-sensing ion channel 1a as a therapeutic target to reverse hypoxic pulmonary hypertension.
Garcia SM, Yellowhair TR, Detweiler ND, Ahmadian R, Herbert LM, Gonzalez Bosc LV, Resta TC, Jernigan NL. Garcia SM, et al. Front Mol Biosci. 2022 Oct 5;9:989809. doi: 10.3389/fmolb.2022.989809. eCollection 2022. Front Mol Biosci. 2022. PMID: 36275633 Free PMC article. - Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.
Zhao YD, Cai L, Mirza MK, Huang X, Geenen DL, Hofmann F, Yuan JX, Zhao YY. Zhao YD, et al. Am J Pathol. 2012 Jun;180(6):2268-75. doi: 10.1016/j.ajpath.2012.02.016. Am J Pathol. 2012. PMID: 22632818 Free PMC article. - New approaches to the treatment of pulmonary hypertension: from bench to bedside.
Murthy SN, Nossaman BD, Kadowitz PJ. Murthy SN, et al. Cardiol Rev. 2010 Mar-Apr;18(2):76-84. doi: 10.1097/CRD.0b013e3181cbcbf3. Cardiol Rev. 2010. PMID: 20160533 Free PMC article. Review. - PAR-3 controls endothelial planar polarity and vascular inflammation under laminar flow.
Hikita T, Mirzapourshafiyi F, Barbacena P, Riddell M, Pasha A, Li M, Kawamura T, Brandes RP, Hirose T, Ohno S, Gerhardt H, Matsuda M, Franco CA, Nakayama M. Hikita T, et al. EMBO Rep. 2018 Sep;19(9):e45253. doi: 10.15252/embr.201745253. Epub 2018 Jul 17. EMBO Rep. 2018. PMID: 30018153 Free PMC article. - Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.
Huang JB, Liu YL, Sun PW, Lv XD, Bo K, Fan XM. Huang JB, et al. Lung. 2010 Jun;188(3):179-89. doi: 10.1007/s00408-010-9233-8. Epub 2010 Mar 6. Lung. 2010. PMID: 20213196 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous